UBS Maintains a 'Neutral' on Patterson Companies (PDCO); Raising 'The Bar' and Estimates
Get Alerts PDCO Hot Sheet
Price: $31.33 --0%
Rating Summary:
6 Buy, 18 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
6 Buy, 18 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
UBS maintains a 'Neutral' on Patterson Companies (NASDAQ: PDCO) price target raised from $32 to $35.
Analyst, Steven Valiquette, said, "PDCO mgmt has shown a consistent recent annual guidance pattern with a view that dental equipment growth is always poised to re-accelerate each fiscal year. After a couple of years of falling short of initial goals, the +4.6% growth generated in FY12 was closer to initial views of “exceeding mid-single-digit growth views” when factoring in one less week in FY12. However, mgmt has once again set the bar high for FY13 by expecting to exceed +5-7% dental equipment market growth."
UBS raises FY13 EPS estimate from $2.07 to $2.12 and FY14 from $2.29 to $2.36.
For an analyst ratings summary and ratings history on Patterson Companies click here. For more ratings news on Patterson Companies click here.
Shares of Patterson Companies closed at $33.45 yesterday.
Analyst, Steven Valiquette, said, "PDCO mgmt has shown a consistent recent annual guidance pattern with a view that dental equipment growth is always poised to re-accelerate each fiscal year. After a couple of years of falling short of initial goals, the +4.6% growth generated in FY12 was closer to initial views of “exceeding mid-single-digit growth views” when factoring in one less week in FY12. However, mgmt has once again set the bar high for FY13 by expecting to exceed +5-7% dental equipment market growth."
UBS raises FY13 EPS estimate from $2.07 to $2.12 and FY14 from $2.29 to $2.36.
For an analyst ratings summary and ratings history on Patterson Companies click here. For more ratings news on Patterson Companies click here.
Shares of Patterson Companies closed at $33.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho
- SmartFinancial (SMBK) PT Raised to $60 at Benchmark on Higher Valuation
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share